Which drugs are considered first-generation antiepileptics that require therapeutic drug monitoring?

• A. Phenobarbital, Phenytoin, Benzodiazepines, Carbamazepine
• B. Ethosuximide and Valproic acid
• C. Gabapentin and Pregabalin
• D. Felbamate and Topiramate

Answer: (A)

Therapeutic drug monitoring is most important for older antiepileptic drugs that have narrow therapeutic windows and highly variable pharmacokinetics. Among the classic first-generation agents, phenobarbital, phenytoin, and carbamazepine are the ones where maintaining the right serum level is crucial to balance seizure control against toxicity, because small changes in dose can lead to big changes in concentration or effects. Phenytoin exhibits saturable (nonlinear) metabolism, so levels can rise quickly with dose adjustments. Carbamazepine induces its own metabolism and other drugs, making its levels and interactions especially unpredictable. Phenobarbital’s sedative effects also rise with increasing levels, so monitoring helps avoid oversedation while keeping seizure control. Benzodiazepines are older drugs too, and in some scenarios clinicians monitor levels to ensure adequate control without excessive sedation, reinforcing their association with monitoring among first-generation options.

In contrast, the other listed drugs are either newer and monitored less routinely (gabapentin, pregabalin, topiramate, felbamate) or are used with a broader therapeutic range and less need for regular level checks. Ethosuximide can be monitored in certain situations, but pairing it with valproic acid doesn’t reflect the classic first-generation group known for routine TDM.